The Patent Finder

Use of Micro-RNA as a Biomarker of Immunomodulatory Drug Activity

Celgene Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2016/043511, filed Jul 22, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,964,354Use of Micro-RNA as a Biomarker of Immunomodulatory Drug Activity
In force
 · High confidence
Celgene CorporationIn force
High confidence
US 10,252,981Methods of Synthesis of (1R,2R,5R)-5-Amino-2-Methylcyclohexanol Hydrochloride and Intermediates Useful Therein
In force
 · High confidence
Celgene CorporationIn force
High confidence
US 10,774,033Methods of Synthesis of (1R,2R,5R)-5-Amino-2-Methylcyclohexanol Hydrochloride and Intermediates Useful Therein
In force
 · Medium confidence
Celgene CorporationIn force
Medium confidence
US 11,192,847Methods of Synthesis of (1R,2R,5R)-5-Amino-2-Methylcyclohexanol Hydrochloride and Intermediates Useful Therein
In force
 · Medium confidence
Celgene CorporationIn force
Medium confidence
US 11,780,801Methods of Synthesis of (1R,2R,5R)-5-Amino-2-Methyl-CYCLOHEXANOL Hydrochloride and Intermediates Useful Therein
In force
 · Medium confidence
Celgene CorporationIn force
Medium confidence
US 10,428,145PD-1 Binding Proteins and Methods of Use Thereof
In force
 · High confidence
Celgene CorporationIn force
High confidence
US 10,766,958Methods of Treating Vitiligo Using PD-1 Binding Antibodies
In force
 · High confidence
Celgene CorporationIn force
High confidence
US 10,751,414Methods of Treating Psoriasis Using PD-1 Binding Antibodies
In force
 · High confidence
Celgene CorporationIn force
High confidence
US 11,096,940Treatment of Hepatocellular Carcinoma Characterized by Hepatitis B Virus Infection
In force
 · High confidence
Celgene CorporationIn force
High confidence
US 10,357,489Antiproliferative Compounds and Methods of Use Thereof
In force
 · High confidence
Celgene CorporationIn force
High confidence
35 more patents in this group · Pro
10 of 45 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 45.
Upgrade to Pro
29 of these are in force and held by Celgene Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited